Home - Broadview Ventures
BioKier is a clinical-stage company developing oral products for the management of lipids and glucose that can be commercialized via 505(b)2 NDA path. These products are designed to mimic bariatric-metabolic surgery which is known to resolve diabetes and improve cardiometabolic health. Completed clinical trials show that BioKier’s approach improves gut hormone secretion and regulation of glucose and lipids.
BioKier has published an article summarizing our pre-clinical and clinical research: “Colonic delivery of nutrients for management of blood glucose in type 2 diabetes patients”. The data validate BioKier’s approach to managing glucose using colon-targeted nutrients. This article was published in pear review journal: Functional Foods in Health and Disease . Below you will find link to the article: http://ffhdj.com/ index.php/ffhd/article/view/ 283/574 . Read More
Dr. George Szewczyk, presented at the 5th Annual World Congress of Food and Nutrition , held November 18-20, 2016, at The Conference Venue – Kaohsiung Exhibition Center in Kaohsiung, Taiwan. Read More
Home - Broadview Ventures